The investigator-initiated study The effect of single kinetic oscillation stimulation treatment on nonallergic rhinitis from the University of Helsinki was published in March 2023 and the results show that Chordate's K.O.S treatment provides patients with non-allergic rhinitis with a subjective symptom improvement for at least 1 year, thus possibly decreasing the need for invasive treatment methods.
"This is another investigator-initiated study that, completely independent of Chordate, shows good results one year after rhinitis treatment with K.O.S. The study results show that K.O.S significantly reduced symptoms for a significant proportion of the 49 patients who participated in the study. This is, of course, another important proof that the treatment can help many people around the world who suffer from chronic rhinitis," says Anders Weilandt, CEO of Chordate.
The study was published in the scientific journal Laryngoscope Investigative Otolaryngology and is the fourth publication in the author Sara Sainio's doctoral thesis Efficacy and Safety of Novel Medical Devices in Rhinology.
Read more about the completed, ongoing, and planned studies on the K.O.S treatment
